News

Saudi Arabia Launches First Modular ATMP Manufacturing Campus Under Vision 2030

Saudi Arabia formally initiated the development of its first modular Advanced Therapy Medicinal Product (ATMP) manufacturing campus, a strategic healthcare infrastructure project aligned with the Kingdom’s National Biotechnology Strategy and Vision 2030 goals. Located within the King Faisal Specialist Hospital & Research Centre in Riyadh, the project is currently in the concept stage and carries an estimated investment of USD 100 million.

The campus represents a pivotal step in localizing the production of cell and gene therapies and enhancing the Kingdom’s capability to support clinical research, drug development, and precision medicine. Unlike traditional facilities that require years to build, this project adopts a modular delivery model, designed to be operational within just 18 months of contract signing. The modular approach not only compresses construction timelines but also ensures scalability and compliance with global Current Good Manufacturing Practice (CGMP) standards.

The facility will include 16 prefabricated production suites, purpose-built for both clinical and commercial manufacturing. It is based on Germfree’s BioGO Box cleanroom platform, designed for rapid deployment and strict biocontainment. The project also emphasizes digital integration, incorporating a fully connected manufacturing execution system to support data-driven operations, quality control, and compliance.

As part of its regulatory framework, the campus will meet international biosafety and product quality standards set by the Saudi Food and Drug Authority (SFDA), the U.S. Food and Drug Administration (FDA), the European Medicines Agency (EMA), and the Biosafety in Microbiological and Biomedical Laboratories (BMBL) guidelines. This level of compliance is expected to position Saudi Arabia as a competitive hub for global pharmaceutical manufacturing and clinical trials.

The project will require specialized contractors familiar with modular cleanroom installation, precision HVAC systems, pharmaceutical-grade MEP (mechanical, electrical, plumbing) works, and digital integration platforms. This creates opportunities for niche suppliers and service providers in sterile environment construction, CGMP facility commissioning, and biocontainment infrastructure.

The launch of this campus not only marks a significant milestone in the Kingdom’s shift toward knowledge-based and high-tech industries but also reflects a growing regional demand for localized pharmaceutical manufacturing. As Saudi Arabia diversifies its economic base, projects like this reinforce the country’s strategic pivot toward biotechnology and advanced healthcare infrastructure.

For more information please visit: https://www.bncnetwork.net/